Latest AI and machine learning research in skin cancer for healthcare professionals.
Tumor-infiltrating lymphocytes (TILs) are capable of recognizing tumor antigens, impacting tumor pro...
Neoadjuvant chemoradiotherapy (NACRT) is the standard treatment for locally advanced rectal cancer (...
RNA interference (RNAi) has emerged as a transformative approach for cancer therapy, enabling precis...
Tumor-associated macrophages (TAMs) are a vital immune component within the tumor microenvironment (...
In the past, the development of vaccines and immunotherapeutics relied heavily on trial-and-error ...
Intervertebral discs are avascular and maintain immune privilege. However, during intervertebral d...
Gene set analysis (GSA) is a foundational approach for interpreting genomic data of diseases by li...
BACKGROUND: The clinical diagnosis of skin lesions involves the analysis of dermoscopic and clinical...
Colon adenocarcinoma (COAD) is one of the most prevalent malignancies worldwide and its prognosis is...
This white paper presents a comprehensive biobanking framework developed at the European Cancer Moon...
We introduce SLIMP (Skin Lesion Image-Metadata Pre-training) for learning rich representations of ...
Accurately predicting immunotherapy response in Non-Small Cell Lung Cancer (NSCLC) remains a criti...
The increased risk of recurrence and metastasis are obstacles to treating TNBC. Propionate-related g...
BACKGROUND: Chaperonin containing TCP1 subunit 5 (CCT5), a vital component of the molecular chaperon...
Kidney renal clear cell carcinoma (KIRC), a cancer characterized by substantial immune infiltration,...
The high incidence and mortality rates of gastric cancer pose a significant burden on human health a...
Breast cancer (BC), one of the most prevalent malignant tumors worldwide, lacks efficacious diagnost...
Artificial intelligence (AI) systems substantially improve dermatologists' diagnostic accuracy for m...
Polygonati Rhizoma, a traditional Chinese medicine, has demonstrated immunomodulatory and anticancer...
Combining molecular classification with clinicopathologic methods improves risk assessment and choos...